Traumatic Brain Injuries Treatment Market Share, Analysis, Trend, Size, Segments, Emerging Technologies, Growth and Forecast to 2032
Traumatic
Brain Injuries Treatment Market Highlights:
Traumatic brain injury (TBI) occurs from a violent
blow or head injury that disturb the normal functioning of the brain. Every
year TBI contributes to a substantial number of death and permanent disability.
Elder age population holds the largest share of global traumatic brain injuries
treatment market due to increasing incidence of road accident and high rate of
hospitalization and is expected to grow staidly during the forecast period.
Whereas based on treatment, medication (drug) segment holds the highest share
of this market. Increasing incidences of road traffic injury and the government
initiatives to fund for traumatic brain injuries project will boost the
traumatic brain injuries treatment market during assessment period.
The traumatic brain injuries treatment market size
was valued at USD 1.7 Billion in 2022. The traumatic brain injuries treatment
industry is projected to grow from USD 1.84 Billion in 2023 to USD 3.54 Billion
by 2032, exhibiting a compound annual growth rate (CAGR) of 8.50% during the
forecast period (2023 - 2032).
However, high cost of treatment and devices may
hamper the growth of global traumatic brain injuries treatment market during the forecast period.
The global traumatic brain injuries treatment market research report is dominated by many market players. The
key players in the market are engaged in new launches of drug and devices to
maintain the strategic collaborations to hold its market position. Recently the
US FDA has approved the blood test to diagnose the traumatic brain injury.
Traumatic
Brain Injuries (TBI) Treatment Market Players
The Global Traumatic brain injuries treatment
market players are Neuren Pharmaceuticals Ltd., Oxygen Biotherapeutics Inc,
Ischemic, Grace Laboratories LLC. Cognosci, Medicortex, Amarantus BioScience
Holdings, Aldagen, TEVA Pharmaceutical Industries Ltd., NeuroScience
Pharmaceuticals, Targacept, BioDirection, Inc., QuesGen Systems, Inc.,
BrainScope Company, Inc., Oculogica, BrainScope Company, Inc, Vasopharm GmbH,
Silver Creek Pharmaceuticals Inc, Stemedica Cell Technologies Inc, Neural
Analytics Inc, Banayan Biomarkers Inc, Zimmer Biomet.
Regional Analysis:
The market in the Americas is expected to dominate
the global traumatic brain injuries treatment market during the forecast period
owing to the increasing incidences of road traffic injuries and increasing
hospitalization of geriatric population due to TBI. Additionally, the growing
incidences of road traffic collision associated with the aging population are
anticipated to boost the growth of the market in this region. Whereas North
America holds the highest global traumatic brain injury treatment market share due to increasing number of TBI patients and
increasing investment by government in research and development activity on
diagnosis management.
The European market is expected to be the
second-largest due to government funding and support of the healthcare sector
coupled with the growing incidence of elderly patients, increasing incidences
of road traffic collision and funding by the government for traumatic imense
brain damage injury project. Moreover, the market in Asia-Pacific is anticipated
to be the fastest-growing during the assessment period owing to growing number
of neurological canters and increasing incidences of road accident. The market
in the Middle East & Africa is likely to account for the smallest share of
this market. The market growth in this region can be attributed to increasing
healthcare expenditure and developing healthcare infrastructure.
Segmentation:
Global traumatic brain injuries treatment market is
further segmented into treatment types and end-users.
Based on treatment types of the market is segmented
into immediate emergency
care, medications, surgery. On basis of medication global traumatic brain
injuries treatment market is further sub-segmented into diuretics, anti-seizure
drugs, coma-inducing drugs, anti-anxiety agent, anti-depressants,
anti-psychotics, analgesic, anti-convulsant and anti-coagulants.
Based on brain surgery equipment, TBI market is further sub-segmented into removing
clotted blood (hematomas), repairing skull fractures, bleeding in the brain,
opening a window in the skull, rehabilitation.
On basis of end-users global TBI market is further
segmented into hospitals, neurologist, rehabilitative canter treatment,
independent pharmacies, and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment